Preoperative u-PAR gene expression in bone marrow indicates the potential power of recurrence in breast cancer cases

Annals of Surgical Oncology

Volumn 16, Issue 7, 2009, Pages 2035-2041

  Mimori, Koshi ^a   Kataoka, Akemi ^a   Yamaguchi, Hiroshi ^b   Masuda, Norikazu ^c   Kosaka, Yoshimasa ^a   Ishii, Hideshi ^a   Ohno, Shinji ^b   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; UROKINASE RECEPTOR;

ARTICLE; BLOOD; BONE MARROW; BONE MARROW METASTASIS; BREAST CANCER; CANCER RECURRENCE; CANCER RELAPSE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE; GENE EXPRESSION; HUMAN; OVERALL SURVIVAL; PREDICTION; PREOPERATIVE EVALUATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; U PAR GENE;

BONE MARROW; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SURVIVAL ANALYSIS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67649220700     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0465-x     Document Type: Article

References (27)

1. Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol. 2001;19: 1468-75.
2. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. New Eng J Med. 2000;342:525-33.
3. Mansi JL, Gogas H, Bliss JM, Gazet JC, Berger U, Coombes RC. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet. 1999;354:197-202.
4. Masuda N, Tamaki Y, Sakita I, et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription- polymerase chain reaction in breast cancer patients. Clin Cancer Res. 2000;6:4176-85.
5. Molino A, Micciolo R, Turazza M, et al. Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat. 1997;45:241-9.
6. Salvadori B, Squicciarini P, Rovini D, et al. Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer. 1990;26:865-7.
7. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. New Eng J Med. 2005; 353:793-802.
8. Masuda TA, Kataoka A, Ohno S, et al. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol. 2005;26:721-30.
9. Heiss MM, Allgayer H, Gruetzner KU, et al. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med. 1995;1:1035-9.
10. Allan AL, Vantyghem SA, Tuck AB, Chambers AF. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis. 2006;26:87-98.
11. Brackstone M, Townson JL, Chambers AF. Tumour dormancy in breast cancer: an update. Breast Cancer Res. 2007;9:208.
12. Demicheli R, Retsky MW, Hrushesky WJ, Baum M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol. 2007;4: 699-710.
13. Laufs S, Schumacher J, Allgayer H. Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/ dormancy, clinical outcome and minimal residual disease. Cell Cycle. Georgetown, Tex 2006;5:1760-71.
14. Iinuma H, Okinaga K, Egami H, et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol. 2006;28:297-306.
15. Holmgren L, O'Reilly M, Folkman J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149-53.
16. Murray C. Tumour dormancy: not so sleepy after all. Nat Med. 1995;1:117-8.
17. Pantel K, Brakenhoff R Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4:448-56.
18. Uhr J, Scheuermann R, Street N, Vitetta E. Cancer dormancy: opportunities for new therapeutic approaches. Nat Med. 1997;3: 505-9.
19. Riethdorf S, Wikman H, Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Oncol. 2008; 123:1991-2006.
20. Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. Apmis. 2008;116:754-70.
21. Allgayer H, Aguirre-Ghiso JA. The urokinase receptor (u-PAR)- a link between tumor cell dormancy and minimal residual disease in bone marrow? Apmis. 2008;116:602-14.
22. Mimori K, Fukagawa T, Kosaka Y, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res. 2008;14:2609-16.
23. Peters BA, Diaz LA, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med. 2005;11:261-2.
24. Hildenbrand R, Glienke W, Magdolen V, Graeff H, Stutte HJ, Schmitt M. Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistry. Histochem Cell Biol. 1998;110:27-32.
25. Schlimok G, Funke I, Pantel K, et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer. 1991;27:1461-5.
26. Dubuisson L, Monvoisin A, Nielsen BS, Le Bail B, Bioulac-Sage P, Rosenbaum J. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma. J Pathol. 2000;190:190-5.
27. Pyke C, Graem N, Ralfkiaer E, et al. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res. 1993;53:1911-5.